(Q58850470)

English

Risk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference category: analysis of the combined prospective cohort of the New Independent States of the F

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Risk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference category: analysis of the combined prospective cohort of the New Independent States of the Former Soviet Union and Latin American Screening studies (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Papillomavirus infections

1 reference

based on heuristic

inferred from title

author name string

K Syrjänen

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

I Shabalova

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

P Naud

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

V Kozachenko

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

S Derchain

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

S Zakharchenko

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

C Roteli-Martins

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

R Nerovjna

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

A Longatto-Filho

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

L Kljukina

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

S Tatti

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

M Branovskaja

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

L S Hammes

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

M Branca

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

V Grunjberga

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

M Eržen

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

A Juschenko

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

S Costa

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

L Sarian

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

J Podistov

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

S Syrjänen

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

NIS and LAMS Study Research Groups

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 June 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

International Journal of STD & AIDS

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

315-323

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Papillomaviruses in the causation of human cancers - a brief historical account

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Clearance of high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study).

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Descriptive Evidence That Risk Profiles for Cervical Intraepithelial Neoplasia 1, 2, and 3 Are Unique

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

The carcinogenicity of human papillomavirus types reflects viral evolution.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

A critique of cohort studies examining the role of human papillomavirus infection in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study co

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Management of women who test positive for high-risk types of human papillomavirus: the HART study

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009365

21 January 2018

Identifiers

10.1258/IJSA.2009.009365

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21680666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58850470&oldid=2120005516"